NASDAQ: KPRX
Kiora Pharmaceuticals Inc Stock Ownership - Who owns Kiora Pharmaceuticals?

Insider buying vs selling

Have Kiora Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carmine N. StengoneDirector2024-09-111,250$3.68
$4.60kBuy
Aron ShapiroDirector2024-09-103,000$3.60
$10.80kBuy
Praveen TyleDirector2024-08-195,000$3.96
$19.80kBuy
Lisa WaltershoffertDirector2024-08-191,250$3.86
$4.83kBuy
Melissa ToscaCFO2024-08-142,000$3.21
$6.42kBuy

1 of 1

KPRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KPRX insiders and whales buy or sell their stock.

KPRX Shareholders

What type of owners hold Kiora Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC245.68%7,478,202$22.58MInsider
Innoven Partenaires Sa Ipsa47.98%1,460,479$4.41MInsider
Ventech Capital II47.04%1,431,814$4.32MInsider
Private Equity Natixis22.15%674,205$2.04MInsider
Barbara Wirostko15.24%463,808$1.40MInsider
Aigh Capital Management LLC8.33%253,555$765.74kInstitution
Rosalind Advisors Inc8.22%250,059$755.18kInstitution
Nantahala Capital Management LLC6.94%211,110$637.55kInstitution
Stonepine Capital Management LLC6.59%200,647$605.95kInstitution
Michael Garanzini6.45%196,250$592.68kInsider

1 of 3

KPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KPRX9.51%90.49%Net Buying
EVGN6.31%0.00%
CYCC0.79%99.21%Net Selling
CAPS0.00%51.09%
MBRX10.46%37.97%Net Selling

Kiora Pharmaceuticals Stock Ownership FAQ

Who owns Kiora Pharmaceuticals?

Kiora Pharmaceuticals (NASDAQ: KPRX) is owned by 42.23% institutional shareholders, 401.60% Kiora Pharmaceuticals insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Kiora Pharmaceuticals shareholder, owning 7.48M shares representing 245.68% of the company. Armistice Capital LLC's Kiora Pharmaceuticals shares are currently valued at $22.58M.

If you're new to stock investing, here's how to buy Kiora Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.